Saffron tablet — Competitive Intelligence Brief

Saffron tablet (Saffron tablet) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal/botanical extract. Area: Psychiatry/Neurology.

marketed Herbal/botanical extract Psychiatry/Neurology Small molecule

Target snapshot

Saffron tablet (Saffron tablet) — Birjand University of Medical Sciences. Saffron (Crocus sativus) exerts therapeutic effects primarily through its active constituents crocin and safranal, which possess antioxidant, anti-inflammatory, and neuroprotective properties.

Comparator set (4 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Saffron tablet TARGET	Saffron tablet	Birjand University of Medical Sciences	marketed	Herbal/botanical extract
Black cohosh	Black cohosh	National Center for Complementary and Integrative Health (NCCIH)	marketed	Herbal/botanical extract
Melaleuca Alternifolia Oil	Melaleuca Alternifolia Oil	Ain Shams University	marketed	Herbal/botanical extract
Acacia catechu	Acacia catechu	Tatyasaheb Kore Dental College	marketed	Herbal/botanical extract
Zingiber officinalis	Zingiber officinalis	Miglani, Anjali	marketed	Herbal/botanical extract

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal/botanical extract class)

1. Ain Shams University · 1 drug in this class
2. Birjand University of Medical Sciences · 1 drug in this class
3. Miglani, Anjali · 1 drug in this class
4. National Center for Complementary and Integrative Health (NCCIH) · 1 drug in this class
5. Tatyasaheb Kore Dental College · 1 drug in this class